Second-line pemetrexed versus docetaxel in Chinese patients with locally advanced or metastatic non-small cell lung cancer: A randomized, open-label study
Authors:
- Y. SunYSY. Sun
- Y.-L. WuYWY.-L. Wu
- C.-C. ZhouCZC.-C. Zhou
- L. ZhangLZL. Zhang
- X.-Y. LiuXLX.-Y. Liu
- S.-Y. YuSYS.-Y. Yu
- G.-L. JiangGJG.-L. Jiang
- K. LiKLK. Li
- S.-K. QinSQS.-K. Qin
- S.-L. MaSMS.-L. Ma
- L. HanLHL. Han
- M. QuinlivanMQM. Quinlivan
- 1 February 2013
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 79 (2) , 143-150
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Cancer Trends in ChinaJapanese Journal of Clinical Oncology, 2010
- PemetrexedDrugs, 2009
- Chemotherapy for Advanced Stage Non-Small Cell Lung CancerSeminars in Thoracic and Cardiovascular Surgery, 2008
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With ChemotherapyJournal of Clinical Oncology, 2004
- Pemetrexed disodium, a novel antifolate with multiple targetsThe Lancet Oncology, 2001
- A Systematic Overview of Chemotherapy Effects in Non-Small Cell Lung CancerActa Oncologica, 2001
- Ethnic Variation in the Thymidylate Synthase Enhancer Region Polymorphism among Caucasian and Asian PopulationsGenomics, 1999
- Multiple folate enzyme inhibition: mechanism of a novel pyrrolopyrimidine-based antifolate LY231514 (MTA)Advances in Enzyme Regulation, 1998